Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Allen

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|March 1, 1993
Effect of hyperbaric and normobaric oxygen on pulmonary endothelial cell functionM C Allen, S J Watt
Obstetrics and Gynecology|March 1, 1986
Medical complications of prematurityM C Allen, M D Jones
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 1, 1996
Histamine forming capacity (HFC) and its modulation by H3 receptor ligands in a model of bronchial hyper-responsivenessM C Allen, P Graham, G Morris
Applied Optics|May 20, 1997
Laser applications to chemical and environmental analysis: an introductionR P Lucht, M C Allen, S Downey
JAAPA : Official Journal of the American Academy of Physician Assistants|August 28, 2001
"Will our baby be normal?" Answering questions asked by parents of premature infantsP K Donohue, S F Baker, M C Allen
The New England Journal of Medicine|November 25, 1993
The limit of viability--neonatal outcome of infants born at 22 to 25 weeks' gestationM C Allen, P K Donohue, A E Dusman
Journal of Chromatography. B, Biomedical Sciences and Applications|August 29, 1997
Quantitation of 4-cyclohexyl-2-hydroxy-3-(3-methylsulfanyl-2- [2-[(morpholine-4-carbonyl)amino]-3-phenylpropionylamino]propi onylamino ) butyric acid isopropyl ester (CP-80,794), a renin inhibitor, and its hydrolytic cleavage metabolite 2-[(morpholine-4-carbonyl)amino]-3-phenylpropionic acid (CP-84,364) in dog and human plasma by high-performance liquid chromatographyM C Allen, C G Stafford, M R Nocerini
Biopharmaceutics & Drug Disposition|April 13, 2000
The pharmacokinetics and metabolism of CP-191,166, an angiotensin II receptor antagonist, in rats and dogsM C Allen, M R Nocerini, W W Day
The American Journal of Otology|November 27, 1998
Speech intelligibility in children after cochlear implantationM C Allen, T P Nikolopoulos, G M O'Donoghue
Pharmaceutical Research|March 6, 1998
Rapid determination of oral pharmacokinetics and plasma free fraction using cocktail approaches: methods and applicationM C Allen, T S Shah, W W Day
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|March 1, 1993
Effect of hyperbaric and normobaric oxygen on pulmonary endothelial cell functionM C Allen, S J Watt
Obstetrics and Gynecology|March 1, 1986
Medical complications of prematurityM C Allen, M D Jones
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 1, 1996
Histamine forming capacity (HFC) and its modulation by H3 receptor ligands in a model of bronchial hyper-responsivenessM C Allen, P Graham, G Morris
Applied Optics|May 20, 1997
Laser applications to chemical and environmental analysis: an introductionR P Lucht, M C Allen, S Downey
JAAPA : Official Journal of the American Academy of Physician Assistants|August 28, 2001
"Will our baby be normal?" Answering questions asked by parents of premature infantsP K Donohue, S F Baker, M C Allen
The New England Journal of Medicine|November 25, 1993
The limit of viability--neonatal outcome of infants born at 22 to 25 weeks' gestationM C Allen, P K Donohue, A E Dusman
Journal of Chromatography. B, Biomedical Sciences and Applications|August 29, 1997
Quantitation of 4-cyclohexyl-2-hydroxy-3-(3-methylsulfanyl-2- [2-[(morpholine-4-carbonyl)amino]-3-phenylpropionylamino]propi onylamino ) butyric acid isopropyl ester (CP-80,794), a renin inhibitor, and its hydrolytic cleavage metabolite 2-[(morpholine-4-carbonyl)amino]-3-phenylpropionic acid (CP-84,364) in dog and human plasma by high-performance liquid chromatographyM C Allen, C G Stafford, M R Nocerini
Biopharmaceutics & Drug Disposition|April 13, 2000
The pharmacokinetics and metabolism of CP-191,166, an angiotensin II receptor antagonist, in rats and dogsM C Allen, M R Nocerini, W W Day
The American Journal of Otology|November 27, 1998
Speech intelligibility in children after cochlear implantationM C Allen, T P Nikolopoulos, G M O'Donoghue
Pharmaceutical Research|March 6, 1998
Rapid determination of oral pharmacokinetics and plasma free fraction using cocktail approaches: methods and applicationM C Allen, T S Shah, W W Day
Pageof 10